Orphan designation: Synthetic oligonucleotide selectively targeting UBE3A antisense RNA transcripts, Treatment of Angelman syndrome, 09/12/2020, Positive

Orphan designation: Synthetic oligonucleotide selectively targeting UBE3A antisense RNA transcripts, Treatment of Angelman syndrome, 09/12/2020, Positive

SEMrush
Orphan designation: Synthetic oligonucleotide selectively targeting UBE3A antisense RNA transcripts, Treatment of Angelman syndrome, 09/12/2020, Positive
[automaticbacklinks]